Different Trends of Immune Activation Markers When Switching to Either Oral or Injectable Dual Antiretroviral Therapy Based on Integrase Inhibitors in People Living with HIV
We found different trends in immune activation markers and risk factors associated with PWH switching to either oral or LA ART, requiring larger studies.
Authors
- Pierre Corbeau (ORCID: https://orcid.org/0000-0002-8576-6683)
- Roxane Fabre (ORCID: https://orcid.org/0000-0001-5670-1322)
- Matteo Vassallo (ORCID: https://orcid.org/0000-0002-3605-3871)
- J. Durant
- Jean-Philippe Bastard
- Christian Pradier
- Jacqueline Capeau
- Soraya Fellahi
Institutions
- Inserm (FR)
- Université Paris-Est Créteil (FR)
- Centre Hospitalier Universitaire de Nice (FR)
- Sorbonne Université (FR)
- Hôpitaux Universitaires Henri-Mondor (FR)
- Centre de Recherche Saint-Antoine (FR)
- Cognition Behaviour Technology (FR)
- Centre Hospitalier de Cannes (FR)
- Université de Nîmes (FR)
Publication Details
- Journal
- Pathogens
- Published
- 2026-03-14
- DOI
- https://doi.org/10.3390/pathogens15030316
- Primary Topic
- HIV-related health complications and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00